VARIVAX

This brand name is authorized in Austria, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Lithuania, Malta, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States

Active ingredients

The drug VARIVAX contains one active pharmaceutical ingredient (API):

1 Varicella, live attenuated
UNII GPV39ZGD8C - VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN

Natural infection induces a cellular and humoral immune response to the varicella-zoster virus, which can be rapidly detected following infection. IgG, IgM and IgA directed against viral proteins usually appear at the same time that a cellular immune response can be demonstrated, making the relative contribution of humoral and cellular immunity to disease progression difficult to ascertain. Vaccination has been shown to induce both humoral and cell-mediated types of immunity.

Read about Varicella, live attenuated

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J07BK01 Varicella, live attenuated J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BK Varicella zoster vaccines
Discover more medicines within J07BK01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 79-MBE-1216
Country: EE Ravimiamet Identifier(s): 1182372, 1182383
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 65709
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 576856
Country: FR Base de données publique des médicaments Identifier(s): 69201849
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 79956
Country: HK Department of Health Drug Office Identifier(s): 39958
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-920622763
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1019610, 1019611, 1019612, 1019613, 1019614, 1019615
Country: MT Medicines Authority Identifier(s): MA224/00501
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 8159
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100420673
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W66309003, W66309004, W66309005, W66309006
Country: SG Health Sciences Authority Identifier(s): 13090P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699636950159
Country: US FDA, National Drug Code Identifier(s): 0006-4826, 0006-4827

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.